中国P站

ISSN: 2476-2024

Diagnostic Pathology: Open Access
Open Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • Diagnos Pathol Open, Vol 11(3)

Intraoperative Localization of Solid Pulmonary Tumors in Children Using Nebulized Indocyanine Green and Fluorescence Thoracoscopy

An Nan Ma, Ye Yin, Didi Zhuansun, Xiao Feng Xiong and Tian Qi Zhu*
Department of Pediatric Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Provience, China
*Corresponding Author: Tian Qi Zhu, Department of Pediatric Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Provience, China, Email: Zhutianqi84@163.com

Received: 24-Sep-2026 / Manuscript No. DPO-26-194713 / Editor assigned: 28-Sep-2026 / PreQC No. DPO-26-194713 / Reviewed: 12-Oct-2026 / QC No. DPO-26-194713 / Revised: 19-Oct-2026 / Manuscript No. DPO-26-194713 / Accepted Date: 26-Oct-2026 / Published Date: 26-Oct-2026

Abstract

Background: To evaluate the feasibility and safety of preoperative nebulized Indocyanine Green (ICG) inhalation combined with fluorescence thoracoscopy for intraoperative precise localization of solid pulmonary tumors in children.

Methods: This prospective, single-center, exploratory study enrolled 8 children with solid pulmonary tumors between January 2024 and March 2025. Patients received nebulized ICG (0.5 mg/kg in 5 mL normal saline) preoperatively in the awake state over 15-20 minutes, and surgery was performed 30-60 minutes later using fluorescence thoracoscopy for real-time tumor localization. Perioperative data, including fluorescence visualization, operative time, resection type, complications, and follow-up, were recorded.

Results: Intraoperative fluorescence visualization of the tumor was successfully achieved in all 8 patients, with clear demarcation from adjacent normal lung tissue. Pathological diagnoses included neuroblastoma metastasis (n=2), hepatoblastoma metastasis (n=1), nephroblastoma metastasis (n=1), inflammatory pseudotumor (n=1), inflammatory myofibroblastic tumor (n=1), pulmonary sclerosing pneumocytoma (n=1) and Castleman disease (n=1). Wedge resection was performed in 2 patients, segmentectomy in 5, and lobectomy in 1. The median operative time was 30 minutes, and the median postoperative hospital stay was 5.5 days (range, 4-7 days). No drug-related adverse reactions or postoperative complications occurred. At a median follow-up of 1 year, no residual tumor or local recurrence was observed.

Conclusion: Nebulized ICG inhalation combined with fluorescence thoracoscopy appears to be a feasible, safe, and effective technique for intraoperative precise localization of solid pulmonary tumors in children, thereby facilitating lung-sparing resection.

Keywords: Solid pulmonary tumors; Pediatric patients; Indocyanine Green (ICG); Nebulized ICG inhalation; Intraoperative tumor localization

Introduction

Precise localization of solid pulmonary tumors in children is a multi-step, multi-technique collaborative process, primarily aimed at accurately identifying and resecting lesions during minimally invasive surgery while maximizing preservation of healthy lung tissue [1]. However, intraoperative precise localization remains a core challenge, particularly for small, deep-seated, or solitary pulmonary solid tumors [2]. Traditional localization techniques for pulmonary nodules in adults, such as preoperative CT-guided placement, are associated with considerable invasiveness, high complication rates and substantial medical costs, which are even more pronounced in the pediatric population.

In recent years, near-infrared fluorescence imaging with Indocyanine Green (ICG) has attracted attention for intraoperative localization of pulmonary nodules. In a preclinical study using animal models and human lung tissue samples. demonstrated that aerosolized ICG administration at a dose 20 times lower than intravenous injection could double the detection efficiency of lung tumors and detect nodules as small as 0.2 cm [3]. A study in adults using intraoperative ICG inhalation showed feasibility for visualizing primary lung cancer during video-assisted thoracoscopic surgery, but did not provide results for pulmonary metastases and benign tumors, which are more common in children [4]. The present study aims to provide the first evidence on the efficacy and safety of preoperative nebulized ICG inhalation for intraoperative visualization and localization of solid pulmonary tumors in children, thereby supporting the broader application of this technique.

Materials and Methods

Study design and participants

This was a prospective, single-center, exploratory study. Eight children with solid pulmonary tumors who underwent surgical treatment in the Department of Pediatric Surgery at our institution between January 2024 and March 2025 were enrolled. Inclusion criteria were as follows: 1) Preoperative imaging diagnosis of a solid pulmonary tumor; 2) absence of obvious respiratory obstructive symptoms; 3) no history of allergy to iodine-containing agents or ICG; and 4) normal hepatic and renal function. Exclusion criteria were as follows: 1) Severe preoperative asthma or inability to cooperate with nebulized inhalation ; 2) severe cardiopulmonary insufficiency; 3) coagulation dysfunction; and (4) refusal of the guardian to participate in the study. This study was approved by the Ethics Committee of our hospital, and informed consent was obtained from the guardians of all enrolled children.

Operative protocol

Before anesthesia induction, the patient inhaled 5 mL of ICG solution dissolved in normal saline at a dose of 0.5 mg/kg in the awake state. The entire ICG inhalation process took approximately 15 to 20 minutes. The patient was then transferred to the operating room, and surgery was started 30 to 60 minutes after ICG administration. Under general anesthesia, the patient was placed in the lateral decubitus position, and one-lung ventilation was initiated. Low-flow (1-2 L/min) and low-pressure (4-5 mm Hg) carbon dioxide insufflation was maintained to establish artificial pneumothorax. The camera port was placed in the 7th or 8th intercostal space along the midaxillary line, and two working ports were placed in the 4th or 5th intercostal space along the anterior axillary line and the 8th or 9th intercostal space along the posterior axillary line, respectively. After entering the thoracic cavity with a 30°, 10-mm fluorescence thoracoscope (OptoMedic, China), the fluorescence endoscope was switched to fluorescence imaging mode. Utilizing the fluorescence enrichment of ICG in tumor tissue, the tumor boundaries and anatomical landmarks were directly identified and the target pulmonary segment or lobe was exposed. The vessels, bronchi, and small branches of the pulmonary artery and pulmonary vein were then sequentially dissected and divided according to the anatomical landmarks to complete lesion resection.

Outcomes and statistical analysis

Preoperative demographic characteristics, including age and sex and clinical baseline information, including tumor location, tumor size and distance from the pleural surface, as well as perioperative data including adverse reactions to nebulization, intraoperative tumor fluorescence visualization, operative time, postoperative complications and postoperative hospital stay, were collected. Follow-up time and residual or recurrent lesions were also recorded.

Continuous data are presented as mean ± standard deviation and range and categorical variables are presented as frequency (%). A P value <0.05 was considered statistically significant. Statistical analyses were performed using SPSS Statistics for Windows, version 19.0 International Business Machines (IBM Corp., Armonk, NY, USA).

Results

Patient characteristics

A total of eight children with solid pulmonary tumors were enrolled. The median age was 2.8 years (range, 1-11 years) and the cohort included four males (50.0%) and four females (50.0%). The median tumor diameter was 15 mm (range, 5-30 mm) and the median distance from the pleural surface was 2 cm (range, 0-6 cm). Tumor locations were as follows: Right upper lobe in 1 patient (12.5%), right middle lobe in 1 patient (12.5%), right lower lobe in 2 patients (25.0%), left upper lobe in 2 patients (25.0%) and left lower lobe in 2 patients (25.0%). All patients completed preoperative nebulized ICG inhalation in the ward. No drug-related adverse reactions such as choking, allergic reactions, or respiratory discomfort were observed and nebulization was well tolerated as shown in Table 1.

NO. Sex Age (years) Lesion location Resection scope Pathological diagnosis
1 Male 1 Left upper Wedge resection Neuroblastoma Metastasis
2 Female 8 Right middle Pulmonary segmentectomy Pulmonary sclerosing pneumocytoma
3 Male 11 Right lower Wedge resection Inflammatory pseudotumor
4 Female 2.3 Left lower Pulmonary segmentectomy Inflammatory myofibroblastic tumor
5 Female 3 Right lower Pulmonary segmentectomy Wilms tumor metastasis
6 Male 3.8 Left lower Pulmonary lobectomy Neuroblastoma Metastasis
7 Female 2 Left upper Pulmonary segmentectomy Hepatoblastoma Metastasis
8 Male 2.6 Right upper Pulmonary segmentectomy Castleman's disease

Table 1: Basic characteristics of patients in this study.

Perioperative outcomes

Postoperative pathological diagnoses were as follows: Neuroblastoma metastasis in 2 patients (25.0%), hepatoblastoma lung metastasis in 1 patients (12.5%), nephroblastoma lung metastasis in 1 patient (12.5%), inflammatory pseudotumor in 1 patient (12.5%), inflammatory myofibroblastic tumor in 1 patient (12.5%), pulmonary sclerosing pneumocytoma in 1 patient (12.5%) and Castleman disease in 1 patient (12.5%). Intraoperative fluorescence visualization of the tumor was successfully achieved in all 8 patients. The fluorescence contrast between tumor tissue and adjacent normal lung tissue was clear, allowing the surgeon to directly identify tumor boundaries without additional intraoperative puncture localization (Figure 1).Wedge resection was performed in 2 patients, segmentectomy in 5 patients and lobectomy in 1 patient with neuroblastoma metastasis because the tumor occupied more than three pulmonary segments. The median operative time was 30 minutes. The median postoperative hospital stay was 5.5 days (range, 4-7 days). No postoperative complications such as pneumothorax, pulmonary hemorrhage, wound infection, or respiratory dysfunction occurred in any patient. The median followup duration was 1 year and no residual tumor or local recurrence was observed during the follow-up period as show in Table 2.

Characteristics Value
Tumor diameter (median (range), mm) 15 (5-30)
Distance from the pleura (median (range), cm) 2 (0-6)
Operative time (median (range), min) 30 (20-60)
Postoperative hospital stay (median (range), day) 5.5 (4-7)
Postoperative complications (%) 0
Postoperative follow-up duration (median (range), month) 12 (10-18)
Residual lesion (%) 0
Lesion recurrence (%) 0

Table 2: Perioperative and follow-up data.

diagnostic

Figure 1: A) Preoperative computed tomography images; B) The intraoperative normal lapascopic presenting; C) Intraoperative fluorescence images of lung tumor.

Discussion

Surgery is a critical modality for achieving remission in children with Primary Lung Tumors (PLTs) [5]. Intraoperative precise localization of solid pulmonary tumors in children represents an integrated system that combines precise preoperative marking and intraoperative intelligent navigation [6]. Advances in imaging technology and intraoperative navigation have improved the accuracy of lesion localization and resection margins while helping to minimize damage to surrounding tissues.

Because solid pulmonary tumors in children are often small, deeply located, and similar in consistency to the adjacent normal lung parenchyma, intraoperative palpation and visual identification are frequently difficult. This is especially true for tiny lesions located deep to the pleural surface. Difficulties in intraoperative localization may prolong operative time, lead to excessive resection of normal lung tissue, or even result in conversion to lobectomy when the lesion cannot be identified. Pediatric surgeons have long sought to balance oncological safety with preservation of lung tissue [7]. However, inaccurate intraoperative judgment of tumor boundaries may result in close or positive surgical margins, thereby increasing the risk of local recurrence. For metastatic lesions, positive margins imply the need for reoperation or disease progression; for low-grade malignant tumors, inadequate margins may also compromise long-term prognosis. In addition, because pediatric lung tissue is soft and highly elastic, the actual intraoperative margin distance may differ from the pathological measurement, further increasing the difficulty of intraoperative assessment and even leading to repeated frozen-section examinations.

Unlike adult solid tumors, which are predominantly pulmonary carcinomas, solid pulmonary tumors in children are often metastatic lesions or benign tumors. For pulmonary metastatic lesions, wedge resection or segmentectomy can achieve complete lesion clearance while preserving as much normal lung tissue as possible, thereby maintaining sufficient pulmonary reserve for children to tolerate subsequent chemotherapy and possible repeat surgery. Benign pulmonary lesions in children, such as inflammatory pseudotumor, pulmonary sclerosing pneumocytoma, and Castleman disease, generally exhibit relatively indolent biological behavior and do not require extensive resection according to the principles for malignant tumors. The core concept of lung-sparing surgery is to balance oncological safety with preservation of pulmonary function, which is particularly applicable to children, a special population whose lung tissue is still in the developmental stage [8]. Only on the basis of precise localization can lung-sparing surgery truly be achieved, allowing complete resection of the lesion while maximally preserving the surrounding normal pulmonary parenchyma.

In the present study, although some lesions were located just beneath the pleura, intraoperative fluorescence imaging still clearly delineated the tumor contour from the surrounding normal lung tissue, enabling millimeter-level precise localization. This technique adheres to the minimally invasive concept of thoracoscopic surgery and requires no additional invasive localization procedures, thereby avoiding the risks of pneumothorax, hemorrhage, and radiation exposure associated with conventional CT-guided puncture localization. At the same time, real-time intraoperative localization significantly reduced intraoperative exploration time and simplified the surgical workflow. The median operative time in this study was 30 minutes, reflecting a marked reduction in the time spent searching for lesions. Shortened operative time not only reduces the impact of anesthesia and surgical trauma on pediatric patients but also contributes to faster postoperative recovery. The median postoperative hospital stay in this cohort was 5.5 days, indicating accelerated recovery after pediatric lung resection.

Combined with the current widespread use of ICG in pediatric diseases, ICG administration appears to be well tolerated and safe in the pediatric population [9]. This technique uses preoperative nebulized inhalation administration, which is simple to perform, does not rely on complex equipment or highly demanding techniques, and can be mastered by clinicians after brief training. This method does not require preoperative localization in the CT suite, thus reducing the need for cross-departmental coordination and facilitating its promotion in medical institutions at various levels. It is particularly suitable for the relatively dispersed volume of pediatric thoracic surgery and can serve as a routine adjunct for intraoperative localization of solid pulmonary tumors in children. With respect to safety, no drug-related adverse reactions such as choking, allergic reactions, or respiratory discomfort were observed during nebulized inhalation in this cohort, and no postoperative complications occurred.

Conclusion

Nebulized ICG inhalation combined with fluorescence thoracoscopy provides a novel and reliable approach for surgery of solid pulmonary tumors in children, addressing the clinical challenge of difficult intraoperative localization encountered with conventional techniques. This study preliminarily validated the efficacy and safety of this technique in the pediatric population. Lung-sparing surgery holds important application value in pediatric thoracic surgery, particularly for metastatic tumors, benign lesions, and selected low-grade malignant tumors.

Declarations

Data availability

 All aggregated data supporting the findings of this study are available within the article tables. Individual鈥憀evel raw clinical data are not publicly available due to patient鈥憄rivacy restrictions, but may be obtained from the corresponding author upon reasonable request.

Authors’ contributions

 A鈥慛.M., Y.Y. and D鈥慏.Z.S. collected and analyzed clinical data; A鈥慛.M. drafted the manuscript; X鈥慒.X. prepared the tables; J鈥慩.F. and T鈥慟.Z. designed the study, revised the manuscript. All authors read and approved the final manuscript.

References

Citation: Ma AN, Yin Y, Zhuansun D, Xiong XF, Zhu TQ, et al.  (2026) Intraoperative Localization of Solid Pulmonary Tumors in Children Using Nebulized Indocyanine Green and Fluorescence Thoracoscopy. Diagnos Pathol Open 11:279.

Copyright: © Ma AN, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 129
  • [From(publication date): 0-0 - Nov 19, 2026]
  • Breakdown by view type
  • HTML page views: 105
  • PDF downloads: 24
International Conferences 2026-27
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top